Lavipharm S.A (LAVI) — Cash Flow Quality Index
Lavipharm S.A (LAVI) has a Cash Flow Quality Index of 1.21x as of June 2022. Operating cash flow of €1.15 Million exceeds net income of €950.50K, indicating high earnings quality where cash backs reported profits. Explore investment intensity of Lavipharm S.A to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Lavipharm S.A Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Lavipharm S.A across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Lavipharm S.A (LAVI) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Lavipharm S.A (2016–2024)
Year-by-year earnings quality comparison for Lavipharm S.A. For live market cap and the full company financial profile, see Lavipharm S.A market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.52x | €4.64 Million | €8.98 Million | ▲ +240.3% |
| 2023 | 0.15x | €284.00K | €1.87 Million | ▼ -96.2% |
| 2022 | 4.01x | €3.35 Million | €834.00K | ▲ +81.1% |
| 2021 | 2.22x | €3.82 Million | €1.72 Million | ▲ +68.4% |
| 2020 | 1.32x | €2.85 Million | €2.17 Million | ▲ +142.4% |
| 2019 | 0.54x | €2.89 Million | €5.33 Million | ▼ -52.1% |
| 2018 | 1.13x | €1.42 Million | €1.25 Million | ▲ +868.5% |
| 2017 | 0.12x | €1.51 Million | €12.93 Million | ▲ +123.2% |
| 2016 | 0.05x | €606.00K | €11.55 Million | — |